Agency Information Collection Activities: Submission for OMB Review; Comment Request
Published Date: 2/9/2026
Notice
Summary
SAMHSA is updating its data collection to keep tracking how well its program fights prescription drug misuse and opioid overdoses. This affects communities, schools, and healthcare providers working to raise awareness and improve prescription safety. The update extends data gathering through the end of current grants, helping measure progress without adding new costs or delays.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Grantees face three-year reporting burden
If you are an SPF Rx grantee or a community subrecipient, SAMHSA will continue collecting program evaluation data through FY2028 (three years) and requires completion of the Annual Reporting Tool (ART), Grantee- and Community-Level PDMP Outcomes Modules, and an annual grantee interview. The notice estimates a total annualized respondent burden of 409.17 hours and $17,522.49 in labor costs, with instrument-level burdens listed as: ART 192 hours ($6,496.51), Grantee PDMP 52 hours ($2,627.25), Community PDMP 134.17 hours ($6,822.38), and Grantee Interview 31 hours ($1,576.35).
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20651, Agency Information Collection Activities Comment Request
SAMHSA is updating its big yearly survey that collects info on places offering substance use and mental health treatment. This helps keep FindTreatment.gov accurate and useful for people looking for help. The changes aim to make data collection easier and better without adding extra work or costs, and they want your feedback by a certain deadline.
2026-20004, Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies
The Department of Health and Human Services just updated the list of labs and testing centers approved to do urine and oral fluid drug tests for federal agencies. If a lab loses its certification, it’s dropped from the list until it’s fixed. This monthly update helps keep drug testing reliable and fair for all federal workers.
2026-19079, Agency Information Collection Activities: Proposed Collection; Comment Request
The Substance Abuse and Mental Health Services Administration (SAMHSA) is planning the 2027 National Survey on Drug Use and Health, which asks people 12 and older about drug use and health. They’re keeping the survey mostly the same but won’t include U.S. territories yet, and they’ll keep paying participants $30 for completing it. SAMHSA wants your feedback on how to make the survey better and easier for people to complete.
2026-17852, Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies
The Department of Health and Human Services (HHS) provides notice of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines) using Urine and the laboratories currently certified to meet the standards of the Mandatory Guidelines using Oral Fluid.
2026-16190, Agency Information Collection Activities: Proposed Collection; Comment Request
2026-15637, Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies
The Department of Health and Human Services (HHS) provides notice of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines) using Urine and the laboratories currently certified to meet the standards of the Mandatory Guidelines using Oral Fluid.
Previous / Next Documents
Previous: 2026-02493, Float Glass Products From the People's Republic of China: Final Affirmative Countervailing Duty Determination
The U.S. Department of Commerce found that Chinese float glass makers got unfair government help in 2023. Because of this, extra taxes (called countervailing duties) will be added to their products when they enter the U.S., starting February 9, 2026. This means U.S. glass companies get a fairer chance, and importers should expect higher costs on Chinese float glass.
Next: 2026-02495, Information Collection Being Reviewed by the Federal Communications Commission Under Delegated Authority
The FCC is checking in on a yearly report that TV stations fill out about extra services they offer. They want to make sure the paperwork isn’t too much trouble and are asking for your thoughts by April 10, 2026. This affects TV stations and small businesses, but no big changes or costs are expected—just keeping things clear and easy.